SCHEMBL5400873

SCHEMBL5400873

O=C1CSCCN1.O=S1(=O)CCCCC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ OR51E2 Q9H255 1/20 0.31
▸ FKBP5 Q13451 1/20 0.30
▸ CRBN Q96SW2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL89026 0.82 — —
SCHEMBL16212435 0.82 — —
Hydrochloric Acid SCHEMBL1524100 0.80 — —
SCHEMBL11556195 0.78 CRBN (0.35) OR51E2FKBP5CRBN
SCHEMBL10082272 0.74 OR51E2 (0.42) OR51E2FKBP5CRBN
SCHEMBL10083633 0.74 OR51E2 (0.42) OR51E2FKBP5CRBN
SCHEMBL1269125 0.73 — —
SCHEMBL14501416 0.72 CRBN (0.37) OR51E2FKBP5CRBN
Hydrochloric Acid SCHEMBL31232406 0.71 — —
SCHEMBL4071271 0.71 OR51E2 (0.34) OR51E2FKBP5CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007503453-A — — 2007-02-22 — — JP claimed
EP-1625112-A1 NOVEL COMPOUNDS FOR TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2006-02-15 — — EP claimed
WO-2004101505-A1 NOVEL COMPOUNDS FOR TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2004-11-25 — — WO claimed
Send feedback